A Phase 3 clinical trial called COPILOT, which will test the antibiotic ColiFin (inhaled colistimethate sodium) in people with…
Articles by Marisa Wexler, MS
BreatheCon 2023 — the seventh annual virtual gathering offering online support for adults with cystic fibrosis (CF) — is…
Among children with cystic fibrosis (CF), bone health tends to become worse with older age — and poor bone…
Having cystic fibrosis (CF) can put a tremendous financial strain on patients: In the U.K., the typical family affected…
The Cystic Fibrosis Foundation is investing up to $15 million in ReCode Therapeutics to support the development of…
A novel inhaled antibiotic that Spexis is developing to treat infections of Pseudomonas aeruginosa — the key bacterial agent of lung…
The Phase 1b/2a clinical trial SWARM–Pa, testing Armata Pharmaceuticals‘ experimental phage therapy AP-PA02 in people with cystic fibrosis…
Claire’s Place Foundation has announced the launch of its fundraising campaign, called #CPFoneinamillion, to support families with…
People with cystic fibrosis (CF) who are treated with Orkambi and Symkevi (Symdeko) in real-world settings tend…
First Wave BioPharma has asked the U.S. Food and Drug Administration (FDA) for permission to start a Phase 2…